NASDAQ
RKLB
Last Price
US $78.81
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Rocket Lab USA, Inc. cash flow to debt ratio of -65.18% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
Rocket Lab USA, Inc.'s free cash flow has decreased 177.46% from $-115.98M last year to $-321.81M, signaling decreasing performance
Financial stability - Healthy debt to equity ratio.
Rocket Lab USA, Inc.'s debt to equity ratio is 0.06, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
Rocket Lab USA, Inc.'s debt has decreased relative to shareholder equity from 1.22 last year to 0.06 today, signaling strengthened financials
Financial risk - Net debt/EBITDA.
Rocket Lab USA, Inc. has negative EBITDA, making leverage ratio unreliable
Financial risk - ICR.
Rocket Lab USA, Inc.'s interest coverage ratio is -24.38, which means that the company struggles to meet interest obligations, signaling financial risk.
Financial stability - Profit margin growth.
Rocket Lab USA, Inc.'s profit margin has increased (-38.36%) in the last year from -43.60% to -26.87%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Rocket Lab USA, Inc.'s short-term assets of $1.37G exceed its short-term liabilities of $334.48M
Decreasing performance - ROA.
Rocket Lab USA, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Rocket Lab USA, Inc.'s return on equity of -12.26%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Rocket Lab USA, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Rocket Lab USA, Inc. had positive net income in only 0.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
Rocket Lab USA, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Rocket Lab USA, Inc. has negative free cash flow, indicating cash burn
Decreasing performance - Healthy earnings growth.
Rocket Lab USA, Inc.'s yearly earnings has decreased 4.22% since last year from $-190.18M to $-198.21M, signaling decreasing performance
Increasing performance - Healthy revenue growth.
Rocket Lab USA, Inc.'s yearly revenue has increased 37.96% since last year from $436.21M to $601.80M, signaling increasing performance
Decreasing performance - ROIC.
ROIC -8.07% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Rocket Lab USA, Inc.'s 3-year revenue CAGR of 41.82% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Rocket Lab USA, Inc. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
Rocket Lab USA, Inc. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Rocket Lab USA, Inc. has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Rocket Lab USA, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Rocket Lab USA, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Rocket Lab USA, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Rocket Lab USA, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - P/B ratio.
Rocket Lab USA, Inc. has a price-to-book ratio of 21.07x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Overvalued - P/S ratio.
Rocket Lab USA, Inc. has a price-to-sales ratio of 70.21x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
-12.26%
Return on equity
ROIC: -8.07%
Valuation History
-247.9X
Price to Earnings
EV/EBITDA: -301.4X
Cash flow
Profit margin
-21.75%
(FY vs FY)
Cash flow Y/Y
-30.32%
(FY vs FY)
Fair Value
Market $78.81
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.